Presenter: Stephen Ko, Research Assistant Professor in the Global Health Department. Dr. Ko will be speaking about a) the introduction of new Hepatitis C Virus (HCV) direct acting agents (DAAs) into LMICs and the b) initiation of national viral hepatitis programs in LMICs in SE Asia (Myanmar, Indonesia, Vietnam, and India) and Africa (Rwanda, Nigeria, and Ethiopia).